Immunis Employee Directory

Immunis corporate office is located in 18301 Von Karman Ave, Irvine, California, 92612, United States and has 11-50 employees.

Immunis Global Presence

globalPresence illustration
North America1-10

Key Employees of Immunis

  • MC
    United States flag for contact location.
    Mark Cabato

    Head of Finance Chief Business Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Index of contact profiles from Immunis

Hundreds of professionals searching for Immunis have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Immunis

Explore people who held key positions, contributed to Immunis's success, and advanced their careers.

  1. Volunteer Staff at OC Animal Care

    Worked as Communications Coordinator

    at Immunis (2022-2023)

    email Karissa Muñoz Email direct Karissa Muñoz Direct

Explore More

People from Similar Companies in the Business Services Industry Located in California, United States

Frequently Asked Questions Regarding Immunis Employees

How many employees does Immunis have?
Immunis has 11-50 employees
Who are Immunis key employees?
Some of Immunis key employees are Mark Cabato
Where is Immunis located?
Immunis’s headquarters are located at 18301 Von Karman Ave, Irvine, California, 92612, United States
How do I contact Immunis?
Immunis Contact Info: Website: www.immunisbiomedical.com
What does Immunis do?

Immunis is a private biotechnology company focused on the development of treatments for age-related and disease-related immune deficits. Immunis has developed a novel method to grow human stem cells for clinical use, and direct them to become highly pure populations of defined cells that secrete factors which benefit immune system development, modu... lation, and health. With age, every person experiences a reduction of factors which benefit immune system development, modulation, and health; the company's technology allows replacement of those factors. The company's product is all natural, all human, and represents a perfectly balanced set of immune modulators in naturally occurring relevant physiological concentrations. Immunis' first clinical trial is a Phase 1/2a study of the effectiveness of STEM in treating muscle atrophy, which every person experiences with age.Read More

Is Immunis a public company?
Immunis is private company therefore does not currently have an official ticker symbol
See more information about Immunis Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.